Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below averageInteger Holdings Corporation, headquartered in Plano, Texas, is one of the world’s largest medical device contract development and manufacturing organizations (“CDMOs”), serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation.
In the company’s own words · 10-K filed Feb 23, 2026 · SEC EDGAR
Business segments
Jun 2026 · $464.1MThe company’s own SEC segment disclosure.
- Cardio And Vascular$280.3M60%
- Cardiac Rhythm Management Neuromodulation$173.7M37%
- Other Markets$10.1M2%
Integer Holdings Corporation (ITGR) reported revenue of $440M in Q1 2026 (quarter ended Apr 3, 2026), up 0.5% from the same quarter a year earlier. That came with a gross margin of 25% and net income of $17M (3.8% of revenue). For the full year FY2025, revenue was $1.85B (+8.0% year on year) and net income $103M. Its largest product in Jun 2026 was Cardio And Vascular at $280M, 60% of the disclosed total, well ahead of Cardiac Rhythm Management Neuromodulation at 37%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.